Immersive v/s Non-immersive Virtual Reality in Enhancing Upper Limb Functions Among Individuals With Subacute Stage Hemiplegia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age28-55
SponsorGulf Medical University

About this trial

The goal of this randomized controlled trial is to compare the effectiveness of immersive virtual reality combined with conventional therapy to the effectiveness of non-immersive virtual reality combined with conventional therapy in enhancing upper limb function in subacute hemiplegic stroke patients.

Eligibility criteria

Qualifiers

Individuals aged 28-55 years.

Diagnosed with hemiplegia due to stroke.

≤ Grade 2 on Modified Ashworth scale.

≤ Stage 2 on Brunnstrom stages of motor recovery.

Disqualifiers

Contraindications for VR therapy, such as severe motion sickness or photosensitive epilepsy, impaired spatial awareness.

Pre-existing neurological conditions such as spinal cord injury, Multiple sclerosis and so affecting upper limb function.

Trial design

Treatments tested in this trial

  • Oculus Quest 3
  • Neofect Smartboard and Tyromotion Myro

Treatment groups

30 Participants
are divided into 2 treatment groups

Sponsors and collaborators